Koyfin Home > Directory > Health Care > Nymox Pharm Corp > EBITDA

Nymox Pharm Corp EBITDA Chart (NYMX)

Nymox Pharm Corp annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Nymox Pharm Corp EBITDA for the quarter ending June 06, 2020 was $-3m a 14.57% decrease of 0m year over year
  • Nymox Pharm Corp EBITDA for the last 12 months ending June 06, 2020 was $-10m a -30.96% increase of 3m year over year
  • Nymox Pharm Corp Annual EBITDA for 2019 was $-13m a 16.63% decrease of -2m from 2018
  • Nymox Pharm Corp Annual EBITDA for 2018 was $-11m a -24.40% increase of 3m from 2017
  • Nymox Pharm Corp Annual EBITDA for 2017 was $-13m a 2.78% decrease of 0m from 2016
Other Income Statement Metrics:
  • Nymox Pharm Corp Net Income for the quarter ending September 09, 2018 was $-3m a -19.24% increase of 1m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX EBITDA Data

06/2020$-3m
03/2020$-3m
12/2019$-2m
09/2019$-3m
06/2019$-5m
03/2019$-3m
12/2018$-3m
09/2018$-3m
06/2018$-2m
03/2018$-3m

Annual NYMX EBITDA Data

2019$-13m
2018$-11m
2017$-13m
2016$-13m
2015$-18m
2014$-5m
2013$-5m
2012$-8m
2011$-10m
2010$-6m